Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Merck Millipore Will Acquire Amnis

by Ann M. Thayer
September 5, 2011 | A version of this story appeared in Volume 89, Issue 36

Merck Millipore, the life sciences division of Germany’s Merck KGaA, will acquire Amnis, a Seattle-based maker of high-speed cell-imaging instrumentation. Using the acquired technology, Millipore will combine flow cytometry and imaging analysis in a single system. Amnis has 40 employees and had sales of $14 million last year. “With Amnis we acquire a business with a talented workforce, a strong intellectual property position, and unique know-how,” says Jonathan DiVincenzo, head of Merck Millipore’s bioscience business.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.